nodes	percent_of_prediction	percent_of_DWPC	metapath
Paricalcitol—CYP3A4—Bexarotene—hematologic cancer	0.035	0.0829	CbGbCtD
Paricalcitol—CYP3A4—Lomustine—hematologic cancer	0.0325	0.0771	CbGbCtD
Paricalcitol—CYP3A4—Busulfan—hematologic cancer	0.0325	0.0771	CbGbCtD
Paricalcitol—CYP3A4—Thiotepa—hematologic cancer	0.029	0.0687	CbGbCtD
Paricalcitol—CYP3A4—Methoxsalen—hematologic cancer	0.0225	0.0534	CbGbCtD
Paricalcitol—CYP3A4—Bortezomib—hematologic cancer	0.0214	0.0508	CbGbCtD
Paricalcitol—CYP3A4—Daunorubicin—hematologic cancer	0.0205	0.0486	CbGbCtD
Paricalcitol—CYP3A4—Cytarabine—hematologic cancer	0.0181	0.0429	CbGbCtD
Paricalcitol—CYP3A4—Teniposide—hematologic cancer	0.0178	0.0422	CbGbCtD
Paricalcitol—CYP3A4—Ifosfamide—hematologic cancer	0.0164	0.039	CbGbCtD
Paricalcitol—CYP3A4—Imatinib—hematologic cancer	0.0157	0.0372	CbGbCtD
Paricalcitol—CYP3A4—Ruxolitinib—hematologic cancer	0.0148	0.0351	CbGbCtD
Paricalcitol—CYP3A4—Nilotinib—hematologic cancer	0.0143	0.0338	CbGbCtD
Paricalcitol—CYP3A4—Vinorelbine—hematologic cancer	0.0142	0.0335	CbGbCtD
Paricalcitol—CYP3A4—Triamcinolone—hematologic cancer	0.0129	0.0307	CbGbCtD
Paricalcitol—CYP3A4—Dasatinib—hematologic cancer	0.0126	0.0299	CbGbCtD
Paricalcitol—CYP3A4—Mitoxantrone—hematologic cancer	0.0125	0.0295	CbGbCtD
Paricalcitol—CYP3A4—Betamethasone—hematologic cancer	0.0111	0.0263	CbGbCtD
Paricalcitol—CYP3A4—Prednisolone—hematologic cancer	0.011	0.026	CbGbCtD
Paricalcitol—CYP3A4—Prednisone—hematologic cancer	0.0103	0.0245	CbGbCtD
Paricalcitol—CYP3A4—Irinotecan—hematologic cancer	0.00981	0.0233	CbGbCtD
Paricalcitol—CYP3A4—Vinblastine—hematologic cancer	0.00872	0.0207	CbGbCtD
Paricalcitol—CYP3A4—Vincristine—hematologic cancer	0.00857	0.0203	CbGbCtD
Paricalcitol—CYP3A4—Etoposide—hematologic cancer	0.00786	0.0186	CbGbCtD
Paricalcitol—CYP3A4—Dexamethasone—hematologic cancer	0.00646	0.0153	CbGbCtD
Paricalcitol—CYP24A1—hematopoietic system—hematologic cancer	0.00645	0.177	CbGeAlD
Paricalcitol—UGT1A4—hematopoietic system—hematologic cancer	0.00645	0.177	CbGeAlD
Paricalcitol—CYP3A4—Doxorubicin—hematologic cancer	0.00536	0.0127	CbGbCtD
Paricalcitol—UGT1A4—blood—hematologic cancer	0.00427	0.117	CbGeAlD
Paricalcitol—CYP24A1—lung—hematologic cancer	0.00375	0.103	CbGeAlD
Paricalcitol—VDR—hematopoietic system—hematologic cancer	0.00355	0.0973	CbGeAlD
Paricalcitol—VDR—blood—hematologic cancer	0.00235	0.0645	CbGeAlD
Paricalcitol—VDR—bone marrow—hematologic cancer	0.00228	0.0624	CbGeAlD
Paricalcitol—VDR—lung—hematologic cancer	0.00206	0.0565	CbGeAlD
Paricalcitol—VDR—testis—hematologic cancer	0.00195	0.0533	CbGeAlD
Paricalcitol—VDR—lymph node—hematologic cancer	0.00141	0.0387	CbGeAlD
Paricalcitol—Calcipotriol—MPO—hematologic cancer	0.00128	0.59	CrCbGaD
Paricalcitol—CYP3A4—hematopoietic system—hematologic cancer	0.00119	0.0325	CbGeAlD
Paricalcitol—Ergocalciferol—AR—hematologic cancer	0.00089	0.41	CrCbGaD
Paricalcitol—CYP3A4—blood—hematologic cancer	0.000787	0.0216	CbGeAlD
Paricalcitol—UGT1A4—Metabolism—PHYH—hematologic cancer	0.000147	0.00107	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—B3GAT1—hematologic cancer	0.000147	0.00107	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—DCK—hematologic cancer	0.000147	0.00107	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ASNS—hematologic cancer	0.000147	0.00107	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—FTCD—hematologic cancer	0.000147	0.00107	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	0.000144	0.00105	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—HDC—hematologic cancer	0.000139	0.00102	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—MYC—hematologic cancer	0.000138	0.00101	CbGpPWpGaD
Paricalcitol—CYP3A4—Constitutive Androstane Receptor Pathway—HSP90AA1—hematologic cancer	0.000135	0.000984	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—SMPD3—hematologic cancer	0.000134	0.000982	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	0.00013	0.000949	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—BCL2—hematologic cancer	0.000129	0.000944	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—RARS—hematologic cancer	0.000128	0.000932	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CDA—hematologic cancer	0.000127	0.000931	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—MDM2—hematologic cancer	0.000127	0.00093	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PC—hematologic cancer	0.000123	0.000896	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—POLR3E—hematologic cancer	0.00012	0.000877	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GBA—hematologic cancer	0.000119	0.000865	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—SLC35B2—hematologic cancer	0.000119	0.000865	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—DCK—hematologic cancer	0.000118	0.000858	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—B3GAT1—hematologic cancer	0.000118	0.000858	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ASNS—hematologic cancer	0.000118	0.000858	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—PARP1—hematologic cancer	0.000115	0.000843	CbGpPWpGaD
Paricalcitol—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—hematologic cancer	0.000113	0.000827	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—HDC—hematologic cancer	0.000111	0.000814	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—JUN—hematologic cancer	0.000111	0.000809	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—MTAP—hematologic cancer	0.000108	0.000791	CbGpPWpGaD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—hematologic cancer	0.000108	0.000787	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—CDKN1A—hematologic cancer	0.000107	0.000784	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—PTEN—hematologic cancer	0.000107	0.000782	CbGpPWpGaD
Paricalcitol—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—hematologic cancer	0.000107	0.000782	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—TET2—hematologic cancer	0.000104	0.00076	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—RARA—hematologic cancer	0.000104	0.00076	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—EP300—hematologic cancer	0.000102	0.000746	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—RPLP1—hematologic cancer	0.000102	0.000745	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CDA—hematologic cancer	0.000102	0.000744	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PC—hematologic cancer	9.81e-05	0.000716	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—NR0B2—hematologic cancer	9.68e-05	0.000707	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—FHL2—hematologic cancer	9.66e-05	0.000705	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—AR—hematologic cancer	9.66e-05	0.000705	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—AKT1—hematologic cancer	9.57e-05	0.000698	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—AGRN—hematologic cancer	9.47e-05	0.000692	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GBA—hematologic cancer	9.47e-05	0.000692	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—SLC35B2—hematologic cancer	9.47e-05	0.000692	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—DNMT3A—hematologic cancer	9.23e-05	0.000674	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—ELL—hematologic cancer	9.1e-05	0.000664	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—SLC35B2—hematologic cancer	8.99e-05	0.000657	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—IDH2—hematologic cancer	8.98e-05	0.000656	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—HMMR—hematologic cancer	8.98e-05	0.000656	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—CDKN2B—hematologic cancer	8.9e-05	0.00065	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—EPHX1—hematologic cancer	8.87e-05	0.000648	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—NCOR2—hematologic cancer	8.74e-05	0.000638	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—MTAP—hematologic cancer	8.67e-05	0.000633	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	8.47e-05	0.000618	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ARNTL—hematologic cancer	8.44e-05	0.000617	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—NCOR1—hematologic cancer	8.44e-05	0.000616	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CA9—hematologic cancer	8.21e-05	0.0006	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ACP5—hematologic cancer	8.21e-05	0.0006	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—TGFB1—hematologic cancer	8.19e-05	0.000598	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NCOR2—hematologic cancer	8.11e-05	0.000592	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—AGO2—hematologic cancer	8.05e-05	0.000588	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—H3F3B—hematologic cancer	7.89e-05	0.000576	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—DNMT3B—hematologic cancer	7.89e-05	0.000576	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—NR3C1—hematologic cancer	7.81e-05	0.00057	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—IDH1—hematologic cancer	7.72e-05	0.000564	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—FHL2—hematologic cancer	7.72e-05	0.000564	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ABCC3—hematologic cancer	7.64e-05	0.000558	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—TXN—hematologic cancer	7.64e-05	0.000558	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GSTO1—hematologic cancer	7.64e-05	0.000558	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—AGRN—hematologic cancer	7.57e-05	0.000553	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—SPHK1—hematologic cancer	7.47e-05	0.000546	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—TP53—hematologic cancer	7.31e-05	0.000534	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—RPS14—hematologic cancer	7.22e-05	0.000527	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—HMMR—hematologic cancer	7.18e-05	0.000524	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—IDH2—hematologic cancer	7.18e-05	0.000524	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—UGT1A1—hematologic cancer	7.18e-05	0.000524	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—NUP98—hematologic cancer	7.1e-05	0.000519	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—SLC22A1—hematologic cancer	6.98e-05	0.00051	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CRABP1—hematologic cancer	6.98e-05	0.00051	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—NUP214—hematologic cancer	6.85e-05	0.0005	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ALOX5—hematologic cancer	6.81e-05	0.000497	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ARNTL—hematologic cancer	6.75e-05	0.000493	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—ESR1—hematologic cancer	6.63e-05	0.000484	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NUP98—hematologic cancer	6.59e-05	0.000481	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CA9—hematologic cancer	6.57e-05	0.000479	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ACP5—hematologic cancer	6.57e-05	0.000479	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NCOR2—hematologic cancer	6.48e-05	0.000473	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—NOTCH1—hematologic cancer	6.41e-05	0.000468	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ADCY7—hematologic cancer	6.4e-05	0.000467	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NCOA3—hematologic cancer	6.4e-05	0.000467	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NUP214—hematologic cancer	6.35e-05	0.000464	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—EIF4EBP1—hematologic cancer	6.31e-05	0.000461	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—HSPB1—hematologic cancer	6.31e-05	0.000461	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.29e-05	0.000459	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—MTR—hematologic cancer	6.23e-05	0.000455	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ABCG2—hematologic cancer	6.23e-05	0.000455	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—IDH1—hematologic cancer	6.17e-05	0.000451	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ENO2—hematologic cancer	6.11e-05	0.000446	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GSTO1—hematologic cancer	6.11e-05	0.000446	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—TXN—hematologic cancer	6.11e-05	0.000446	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ABCC3—hematologic cancer	6.11e-05	0.000446	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—SMC1A—hematologic cancer	6.04e-05	0.000441	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—SPHK1—hematologic cancer	5.97e-05	0.000436	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GSTT1—hematologic cancer	5.92e-05	0.000432	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—H3F3A—hematologic cancer	5.92e-05	0.000432	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.83e-05	0.000426	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—CREBBP—hematologic cancer	5.81e-05	0.000424	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—GSTO1—hematologic cancer	5.8e-05	0.000423	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—SDC1—hematologic cancer	5.79e-05	0.000423	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—UGT1A1—hematologic cancer	5.74e-05	0.000419	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—GSTO1—hematologic cancer	5.72e-05	0.000417	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—EZH2—hematologic cancer	5.68e-05	0.000415	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—SLC22A1—hematologic cancer	5.58e-05	0.000408	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CRABP1—hematologic cancer	5.58e-05	0.000408	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—PARP1—hematologic cancer	5.56e-05	0.000406	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.53e-05	0.000404	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.46e-05	0.000398	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—UGT1A1—hematologic cancer	5.45e-05	0.000398	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ALOX5—hematologic cancer	5.44e-05	0.000397	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—UGT1A1—hematologic cancer	5.37e-05	0.000392	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—HDAC2—hematologic cancer	5.36e-05	0.000392	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NUP98—hematologic cancer	5.27e-05	0.000385	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.22e-05	0.000381	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ADCY7—hematologic cancer	5.12e-05	0.000374	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NCOA3—hematologic cancer	5.12e-05	0.000374	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NUP214—hematologic cancer	5.08e-05	0.000371	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—MTR—hematologic cancer	4.98e-05	0.000363	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ABCG2—hematologic cancer	4.98e-05	0.000363	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CD44—hematologic cancer	4.92e-05	0.000359	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NQO1—hematologic cancer	4.92e-05	0.000359	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ENO2—hematologic cancer	4.88e-05	0.000356	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.82e-05	0.000352	CbGpPWpGaD
Paricalcitol—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	4.81e-05	0.000351	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GSTT1—hematologic cancer	4.73e-05	0.000346	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—MTR—hematologic cancer	4.72e-05	0.000345	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CYCS—hematologic cancer	4.66e-05	0.00034	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—AR—hematologic cancer	4.65e-05	0.00034	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—HSP90AA1—hematologic cancer	4.63e-05	0.000338	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—SDC1—hematologic cancer	4.63e-05	0.000338	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	4.49e-05	0.000328	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—CDKN2B—hematologic cancer	4.29e-05	0.000313	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.16e-05	0.000304	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GSTP1—hematologic cancer	4.1e-05	0.0003	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—NCOR1—hematologic cancer	4.06e-05	0.000297	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.97e-05	0.00029	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NQO1—hematologic cancer	3.93e-05	0.000287	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CD44—hematologic cancer	3.93e-05	0.000287	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ABCB1—hematologic cancer	3.89e-05	0.000284	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GSTM1—hematologic cancer	3.77e-05	0.000275	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NCOR1—hematologic cancer	3.77e-05	0.000275	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—NR3C1—hematologic cancer	3.76e-05	0.000275	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CYCS—hematologic cancer	3.72e-05	0.000272	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—HSP90AA1—hematologic cancer	3.7e-05	0.00027	CbGpPWpGaD
Paricalcitol—Skin disorder—Prednisone—hematologic cancer	3.68e-05	9.15e-05	CcSEcCtD
Paricalcitol—Nausea—Gemcitabine—hematologic cancer	3.68e-05	9.14e-05	CcSEcCtD
Paricalcitol—Vomiting—Cisplatin—hematologic cancer	3.67e-05	9.12e-05	CcSEcCtD
Paricalcitol—Hyperhidrosis—Prednisone—hematologic cancer	3.66e-05	9.1e-05	CcSEcCtD
Paricalcitol—Mental disorder—Epirubicin—hematologic cancer	3.65e-05	9.08e-05	CcSEcCtD
Paricalcitol—Rash—Cisplatin—hematologic cancer	3.64e-05	9.04e-05	CcSEcCtD
Paricalcitol—Dermatitis—Cisplatin—hematologic cancer	3.64e-05	9.03e-05	CcSEcCtD
Paricalcitol—Malnutrition—Epirubicin—hematologic cancer	3.63e-05	9.02e-05	CcSEcCtD
Paricalcitol—Diarrhoea—Etoposide—hematologic cancer	3.62e-05	8.99e-05	CcSEcCtD
Paricalcitol—Anorexia—Prednisone—hematologic cancer	3.61e-05	8.98e-05	CcSEcCtD
Paricalcitol—Eye disorder—Doxorubicin—hematologic cancer	3.61e-05	8.96e-05	CcSEcCtD
Paricalcitol—Ill-defined disorder—Methotrexate—hematologic cancer	3.6e-05	8.95e-05	CcSEcCtD
Paricalcitol—Anaemia—Methotrexate—hematologic cancer	3.59e-05	8.91e-05	CcSEcCtD
Paricalcitol—Feeling abnormal—Betamethasone—hematologic cancer	3.59e-05	8.91e-05	CcSEcCtD
Paricalcitol—Feeling abnormal—Dexamethasone—hematologic cancer	3.59e-05	8.91e-05	CcSEcCtD
Paricalcitol—Cardiac disorder—Doxorubicin—hematologic cancer	3.58e-05	8.9e-05	CcSEcCtD
Paricalcitol—Tension—Epirubicin—hematologic cancer	3.56e-05	8.85e-05	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.56e-05	8.84e-05	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Betamethasone—hematologic cancer	3.56e-05	8.84e-05	CcSEcCtD
Paricalcitol—Dysgeusia—Epirubicin—hematologic cancer	3.56e-05	8.84e-05	CcSEcCtD
Paricalcitol—Hypersensitivity—Triamcinolone—hematologic cancer	3.53e-05	8.78e-05	CcSEcCtD
Paricalcitol—Nervousness—Epirubicin—hematologic cancer	3.53e-05	8.76e-05	CcSEcCtD
Paricalcitol—Back pain—Epirubicin—hematologic cancer	3.51e-05	8.73e-05	CcSEcCtD
Paricalcitol—Angiopathy—Doxorubicin—hematologic cancer	3.5e-05	8.7e-05	CcSEcCtD
Paricalcitol—Malaise—Methotrexate—hematologic cancer	3.5e-05	8.7e-05	CcSEcCtD
Paricalcitol—Dizziness—Etoposide—hematologic cancer	3.5e-05	8.69e-05	CcSEcCtD
Paricalcitol—Muscle spasms—Epirubicin—hematologic cancer	3.49e-05	8.68e-05	CcSEcCtD
Paricalcitol—Immune system disorder—Doxorubicin—hematologic cancer	3.49e-05	8.66e-05	CcSEcCtD
Paricalcitol—Vertigo—Methotrexate—hematologic cancer	3.49e-05	8.66e-05	CcSEcCtD
Paricalcitol—Mediastinal disorder—Doxorubicin—hematologic cancer	3.48e-05	8.64e-05	CcSEcCtD
Paricalcitol—Leukopenia—Methotrexate—hematologic cancer	3.47e-05	8.63e-05	CcSEcCtD
Paricalcitol—Chills—Doxorubicin—hematologic cancer	3.46e-05	8.61e-05	CcSEcCtD
Paricalcitol—Urticaria—Betamethasone—hematologic cancer	3.46e-05	8.59e-05	CcSEcCtD
Paricalcitol—Urticaria—Dexamethasone—hematologic cancer	3.46e-05	8.59e-05	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.45e-05	8.58e-05	CcSEcCtD
Paricalcitol—VDR—Generic Transcription Pathway—MYC—hematologic cancer	3.45e-05	0.000252	CbGpPWpGaD
Paricalcitol—Dizziness—Prednisolone—hematologic cancer	3.45e-05	8.57e-05	CcSEcCtD
Paricalcitol—Arrhythmia—Doxorubicin—hematologic cancer	3.45e-05	8.57e-05	CcSEcCtD
Paricalcitol—Asthenia—Triamcinolone—hematologic cancer	3.44e-05	8.55e-05	CcSEcCtD
Paricalcitol—Abdominal pain—Dexamethasone—hematologic cancer	3.44e-05	8.55e-05	CcSEcCtD
Paricalcitol—Body temperature increased—Betamethasone—hematologic cancer	3.44e-05	8.55e-05	CcSEcCtD
Paricalcitol—Abdominal pain—Betamethasone—hematologic cancer	3.44e-05	8.55e-05	CcSEcCtD
Paricalcitol—Body temperature increased—Dexamethasone—hematologic cancer	3.44e-05	8.55e-05	CcSEcCtD
Paricalcitol—Nausea—Cisplatin—hematologic cancer	3.43e-05	8.52e-05	CcSEcCtD
Paricalcitol—Insomnia—Prednisone—hematologic cancer	3.43e-05	8.52e-05	CcSEcCtD
Paricalcitol—Alopecia—Doxorubicin—hematologic cancer	3.41e-05	8.48e-05	CcSEcCtD
Paricalcitol—Paraesthesia—Prednisone—hematologic cancer	3.4e-05	8.46e-05	CcSEcCtD
Paricalcitol—Pruritus—Triamcinolone—hematologic cancer	3.39e-05	8.43e-05	CcSEcCtD
Paricalcitol—Cough—Methotrexate—hematologic cancer	3.39e-05	8.41e-05	CcSEcCtD
Paricalcitol—Mental disorder—Doxorubicin—hematologic cancer	3.38e-05	8.4e-05	CcSEcCtD
Paricalcitol—Ill-defined disorder—Epirubicin—hematologic cancer	3.37e-05	8.37e-05	CcSEcCtD
Paricalcitol—Vomiting—Etoposide—hematologic cancer	3.36e-05	8.35e-05	CcSEcCtD
Paricalcitol—Malnutrition—Doxorubicin—hematologic cancer	3.36e-05	8.35e-05	CcSEcCtD
Paricalcitol—Anaemia—Epirubicin—hematologic cancer	3.36e-05	8.34e-05	CcSEcCtD
Paricalcitol—Agitation—Epirubicin—hematologic cancer	3.34e-05	8.29e-05	CcSEcCtD
Paricalcitol—Dyspepsia—Prednisone—hematologic cancer	3.34e-05	8.29e-05	CcSEcCtD
Paricalcitol—Rash—Etoposide—hematologic cancer	3.33e-05	8.28e-05	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—MTHFR—hematologic cancer	3.33e-05	0.000243	CbGpPWpGaD
Paricalcitol—Dermatitis—Etoposide—hematologic cancer	3.33e-05	8.28e-05	CcSEcCtD
Paricalcitol—Headache—Etoposide—hematologic cancer	3.31e-05	8.23e-05	CcSEcCtD
Paricalcitol—Arthralgia—Methotrexate—hematologic cancer	3.3e-05	8.21e-05	CcSEcCtD
Paricalcitol—Chest pain—Methotrexate—hematologic cancer	3.3e-05	8.21e-05	CcSEcCtD
Paricalcitol—Myalgia—Methotrexate—hematologic cancer	3.3e-05	8.21e-05	CcSEcCtD
Paricalcitol—Tension—Doxorubicin—hematologic cancer	3.3e-05	8.19e-05	CcSEcCtD
Paricalcitol—Decreased appetite—Prednisone—hematologic cancer	3.29e-05	8.19e-05	CcSEcCtD
Paricalcitol—Dysgeusia—Doxorubicin—hematologic cancer	3.29e-05	8.18e-05	CcSEcCtD
Paricalcitol—Rash—Prednisolone—hematologic cancer	3.29e-05	8.17e-05	CcSEcCtD
Paricalcitol—Dermatitis—Prednisolone—hematologic cancer	3.28e-05	8.16e-05	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—GSTP1—hematologic cancer	3.28e-05	0.00024	CbGpPWpGaD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	3.28e-05	8.15e-05	CcSEcCtD
Paricalcitol—Malaise—Epirubicin—hematologic cancer	3.27e-05	8.14e-05	CcSEcCtD
Paricalcitol—Fatigue—Prednisone—hematologic cancer	3.27e-05	8.12e-05	CcSEcCtD
Paricalcitol—Headache—Prednisolone—hematologic cancer	3.27e-05	8.12e-05	CcSEcCtD
Paricalcitol—Discomfort—Methotrexate—hematologic cancer	3.26e-05	8.11e-05	CcSEcCtD
Paricalcitol—Nervousness—Doxorubicin—hematologic cancer	3.26e-05	8.11e-05	CcSEcCtD
Paricalcitol—Vertigo—Epirubicin—hematologic cancer	3.26e-05	8.11e-05	CcSEcCtD
Paricalcitol—Syncope—Epirubicin—hematologic cancer	3.26e-05	8.09e-05	CcSEcCtD
Paricalcitol—VDR—Gene Expression—MAPK14—hematologic cancer	3.26e-05	0.000238	CbGpPWpGaD
Paricalcitol—Leukopenia—Epirubicin—hematologic cancer	3.25e-05	8.08e-05	CcSEcCtD
Paricalcitol—Back pain—Doxorubicin—hematologic cancer	3.25e-05	8.08e-05	CcSEcCtD
Paricalcitol—Constipation—Prednisone—hematologic cancer	3.24e-05	8.05e-05	CcSEcCtD
Paricalcitol—Muscle spasms—Doxorubicin—hematologic cancer	3.23e-05	8.03e-05	CcSEcCtD
Paricalcitol—Palpitations—Epirubicin—hematologic cancer	3.21e-05	7.97e-05	CcSEcCtD
Paricalcitol—Confusional state—Methotrexate—hematologic cancer	3.19e-05	7.93e-05	CcSEcCtD
Paricalcitol—VDR—Gene Expression—ESR1—hematologic cancer	3.19e-05	0.000233	CbGpPWpGaD
Paricalcitol—Loss of consciousness—Epirubicin—hematologic cancer	3.19e-05	7.93e-05	CcSEcCtD
Paricalcitol—Dizziness—Triamcinolone—hematologic cancer	3.17e-05	7.88e-05	CcSEcCtD
Paricalcitol—Cough—Epirubicin—hematologic cancer	3.17e-05	7.87e-05	CcSEcCtD
Paricalcitol—Infection—Methotrexate—hematologic cancer	3.15e-05	7.82e-05	CcSEcCtD
Paricalcitol—Nausea—Etoposide—hematologic cancer	3.14e-05	7.8e-05	CcSEcCtD
Paricalcitol—Hypertension—Epirubicin—hematologic cancer	3.14e-05	7.79e-05	CcSEcCtD
Paricalcitol—Feeling abnormal—Prednisone—hematologic cancer	3.12e-05	7.76e-05	CcSEcCtD
Paricalcitol—Asthenia—Betamethasone—hematologic cancer	3.12e-05	7.76e-05	CcSEcCtD
Paricalcitol—Asthenia—Dexamethasone—hematologic cancer	3.12e-05	7.76e-05	CcSEcCtD
Paricalcitol—Ill-defined disorder—Doxorubicin—hematologic cancer	3.12e-05	7.75e-05	CcSEcCtD
Paricalcitol—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	3.11e-05	0.000227	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ABCB1—hematologic cancer	3.11e-05	0.000227	CbGpPWpGaD
Paricalcitol—Nervous system disorder—Methotrexate—hematologic cancer	3.11e-05	7.72e-05	CcSEcCtD
Paricalcitol—Anaemia—Doxorubicin—hematologic cancer	3.11e-05	7.72e-05	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Prednisone—hematologic cancer	3.1e-05	7.7e-05	CcSEcCtD
Paricalcitol—Nausea—Prednisolone—hematologic cancer	3.1e-05	7.7e-05	CcSEcCtD
Paricalcitol—Myalgia—Epirubicin—hematologic cancer	3.09e-05	7.68e-05	CcSEcCtD
Paricalcitol—Arthralgia—Epirubicin—hematologic cancer	3.09e-05	7.68e-05	CcSEcCtD
Paricalcitol—Chest pain—Epirubicin—hematologic cancer	3.09e-05	7.68e-05	CcSEcCtD
Paricalcitol—Agitation—Doxorubicin—hematologic cancer	3.09e-05	7.67e-05	CcSEcCtD
Paricalcitol—VDR—Gene Expression—NOTCH1—hematologic cancer	3.09e-05	0.000225	CbGpPWpGaD
Paricalcitol—Anxiety—Epirubicin—hematologic cancer	3.08e-05	7.66e-05	CcSEcCtD
Paricalcitol—Pruritus—Dexamethasone—hematologic cancer	3.08e-05	7.65e-05	CcSEcCtD
Paricalcitol—Pruritus—Betamethasone—hematologic cancer	3.08e-05	7.65e-05	CcSEcCtD
Paricalcitol—Skin disorder—Methotrexate—hematologic cancer	3.08e-05	7.64e-05	CcSEcCtD
Paricalcitol—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	3.07e-05	0.000224	CbGpPWpGaD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	3.07e-05	7.63e-05	CcSEcCtD
Paricalcitol—Hyperhidrosis—Methotrexate—hematologic cancer	3.06e-05	7.61e-05	CcSEcCtD
Paricalcitol—Discomfort—Epirubicin—hematologic cancer	3.05e-05	7.59e-05	CcSEcCtD
Paricalcitol—Vomiting—Triamcinolone—hematologic cancer	3.05e-05	7.58e-05	CcSEcCtD
Paricalcitol—Malaise—Doxorubicin—hematologic cancer	3.03e-05	7.53e-05	CcSEcCtD
Paricalcitol—Rash—Triamcinolone—hematologic cancer	3.02e-05	7.51e-05	CcSEcCtD
Paricalcitol—Dry mouth—Epirubicin—hematologic cancer	3.02e-05	7.51e-05	CcSEcCtD
Paricalcitol—Dermatitis—Triamcinolone—hematologic cancer	3.02e-05	7.51e-05	CcSEcCtD
Paricalcitol—Vertigo—Doxorubicin—hematologic cancer	3.02e-05	7.5e-05	CcSEcCtD
Paricalcitol—Anorexia—Methotrexate—hematologic cancer	3.02e-05	7.5e-05	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—GSTM1—hematologic cancer	3.02e-05	0.00022	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NCOR1—hematologic cancer	3.02e-05	0.00022	CbGpPWpGaD
Paricalcitol—Syncope—Doxorubicin—hematologic cancer	3.01e-05	7.49e-05	CcSEcCtD
Paricalcitol—Urticaria—Prednisone—hematologic cancer	3.01e-05	7.48e-05	CcSEcCtD
Paricalcitol—Leukopenia—Doxorubicin—hematologic cancer	3.01e-05	7.47e-05	CcSEcCtD
Paricalcitol—Headache—Triamcinolone—hematologic cancer	3e-05	7.47e-05	CcSEcCtD
Paricalcitol—Abdominal pain—Prednisone—hematologic cancer	3e-05	7.44e-05	CcSEcCtD
Paricalcitol—Body temperature increased—Prednisone—hematologic cancer	3e-05	7.44e-05	CcSEcCtD
Paricalcitol—Confusional state—Epirubicin—hematologic cancer	2.99e-05	7.43e-05	CcSEcCtD
Paricalcitol—Diarrhoea—Dexamethasone—hematologic cancer	2.98e-05	7.4e-05	CcSEcCtD
Paricalcitol—Diarrhoea—Betamethasone—hematologic cancer	2.98e-05	7.4e-05	CcSEcCtD
Paricalcitol—Palpitations—Doxorubicin—hematologic cancer	2.97e-05	7.38e-05	CcSEcCtD
Paricalcitol—Oedema—Epirubicin—hematologic cancer	2.96e-05	7.36e-05	CcSEcCtD
Paricalcitol—Hypotension—Methotrexate—hematologic cancer	2.96e-05	7.35e-05	CcSEcCtD
Paricalcitol—Loss of consciousness—Doxorubicin—hematologic cancer	2.95e-05	7.34e-05	CcSEcCtD
Paricalcitol—Infection—Epirubicin—hematologic cancer	2.94e-05	7.32e-05	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.94e-05	0.000214	CbGpPWpGaD
Paricalcitol—Cough—Doxorubicin—hematologic cancer	2.93e-05	7.29e-05	CcSEcCtD
Paricalcitol—Shock—Epirubicin—hematologic cancer	2.92e-05	7.25e-05	CcSEcCtD
Paricalcitol—Nervous system disorder—Epirubicin—hematologic cancer	2.91e-05	7.22e-05	CcSEcCtD
Paricalcitol—Hypertension—Doxorubicin—hematologic cancer	2.9e-05	7.21e-05	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.89e-05	7.17e-05	CcSEcCtD
Paricalcitol—Skin disorder—Epirubicin—hematologic cancer	2.88e-05	7.15e-05	CcSEcCtD
Paricalcitol—Dizziness—Betamethasone—hematologic cancer	2.88e-05	7.15e-05	CcSEcCtD
Paricalcitol—Dizziness—Dexamethasone—hematologic cancer	2.88e-05	7.15e-05	CcSEcCtD
Paricalcitol—Hyperhidrosis—Epirubicin—hematologic cancer	2.87e-05	7.12e-05	CcSEcCtD
Paricalcitol—Insomnia—Methotrexate—hematologic cancer	2.86e-05	7.12e-05	CcSEcCtD
Paricalcitol—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	2.86e-05	0.000209	CbGpPWpGaD
Paricalcitol—Myalgia—Doxorubicin—hematologic cancer	2.86e-05	7.11e-05	CcSEcCtD
Paricalcitol—Chest pain—Doxorubicin—hematologic cancer	2.86e-05	7.11e-05	CcSEcCtD
Paricalcitol—Arthralgia—Doxorubicin—hematologic cancer	2.86e-05	7.11e-05	CcSEcCtD
Paricalcitol—Anxiety—Doxorubicin—hematologic cancer	2.85e-05	7.08e-05	CcSEcCtD
Paricalcitol—Nausea—Triamcinolone—hematologic cancer	2.85e-05	7.08e-05	CcSEcCtD
Paricalcitol—Paraesthesia—Methotrexate—hematologic cancer	2.84e-05	7.07e-05	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.84e-05	7.06e-05	CcSEcCtD
Paricalcitol—Discomfort—Doxorubicin—hematologic cancer	2.83e-05	7.02e-05	CcSEcCtD
Paricalcitol—Anorexia—Epirubicin—hematologic cancer	2.83e-05	7.02e-05	CcSEcCtD
Paricalcitol—Dyspnoea—Methotrexate—hematologic cancer	2.82e-05	7.02e-05	CcSEcCtD
Paricalcitol—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	2.82e-05	0.000206	CbGpPWpGaD
Paricalcitol—Somnolence—Methotrexate—hematologic cancer	2.82e-05	7e-05	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—PIK3CG—hematologic cancer	2.8e-05	0.000204	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—CREBBP—hematologic cancer	2.8e-05	0.000204	CbGpPWpGaD
Paricalcitol—Dry mouth—Doxorubicin—hematologic cancer	2.8e-05	6.95e-05	CcSEcCtD
Paricalcitol—Hypersensitivity—Prednisone—hematologic cancer	2.79e-05	6.94e-05	CcSEcCtD
Paricalcitol—Dyspepsia—Methotrexate—hematologic cancer	2.79e-05	6.93e-05	CcSEcCtD
Paricalcitol—Hypotension—Epirubicin—hematologic cancer	2.77e-05	6.88e-05	CcSEcCtD
Paricalcitol—Vomiting—Betamethasone—hematologic cancer	2.77e-05	6.87e-05	CcSEcCtD
Paricalcitol—Vomiting—Dexamethasone—hematologic cancer	2.77e-05	6.87e-05	CcSEcCtD
Paricalcitol—Confusional state—Doxorubicin—hematologic cancer	2.77e-05	6.87e-05	CcSEcCtD
Paricalcitol—Decreased appetite—Methotrexate—hematologic cancer	2.75e-05	6.84e-05	CcSEcCtD
Paricalcitol—Rash—Betamethasone—hematologic cancer	2.74e-05	6.82e-05	CcSEcCtD
Paricalcitol—Rash—Dexamethasone—hematologic cancer	2.74e-05	6.82e-05	CcSEcCtD
Paricalcitol—Oedema—Doxorubicin—hematologic cancer	2.74e-05	6.81e-05	CcSEcCtD
Paricalcitol—Dermatitis—Dexamethasone—hematologic cancer	2.74e-05	6.81e-05	CcSEcCtD
Paricalcitol—Dermatitis—Betamethasone—hematologic cancer	2.74e-05	6.81e-05	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.73e-05	6.79e-05	CcSEcCtD
Paricalcitol—Fatigue—Methotrexate—hematologic cancer	2.73e-05	6.78e-05	CcSEcCtD
Paricalcitol—Headache—Betamethasone—hematologic cancer	2.73e-05	6.77e-05	CcSEcCtD
Paricalcitol—Headache—Dexamethasone—hematologic cancer	2.73e-05	6.77e-05	CcSEcCtD
Paricalcitol—Infection—Doxorubicin—hematologic cancer	2.72e-05	6.77e-05	CcSEcCtD
Paricalcitol—Asthenia—Prednisone—hematologic cancer	2.72e-05	6.76e-05	CcSEcCtD
Paricalcitol—Pain—Methotrexate—hematologic cancer	2.71e-05	6.73e-05	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.7e-05	6.71e-05	CcSEcCtD
Paricalcitol—Shock—Doxorubicin—hematologic cancer	2.7e-05	6.7e-05	CcSEcCtD
Paricalcitol—Nervous system disorder—Doxorubicin—hematologic cancer	2.69e-05	6.68e-05	CcSEcCtD
Paricalcitol—Pruritus—Prednisone—hematologic cancer	2.68e-05	6.66e-05	CcSEcCtD
Paricalcitol—Insomnia—Epirubicin—hematologic cancer	2.68e-05	6.66e-05	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—MTHFR—hematologic cancer	2.66e-05	0.000195	CbGpPWpGaD
Paricalcitol—Skin disorder—Doxorubicin—hematologic cancer	2.66e-05	6.62e-05	CcSEcCtD
Paricalcitol—Paraesthesia—Epirubicin—hematologic cancer	2.66e-05	6.61e-05	CcSEcCtD
Paricalcitol—Hyperhidrosis—Doxorubicin—hematologic cancer	2.65e-05	6.59e-05	CcSEcCtD
Paricalcitol—Dyspnoea—Epirubicin—hematologic cancer	2.64e-05	6.57e-05	CcSEcCtD
Paricalcitol—Somnolence—Epirubicin—hematologic cancer	2.63e-05	6.55e-05	CcSEcCtD
Paricalcitol—Anorexia—Doxorubicin—hematologic cancer	2.61e-05	6.5e-05	CcSEcCtD
Paricalcitol—Feeling abnormal—Methotrexate—hematologic cancer	2.61e-05	6.48e-05	CcSEcCtD
Paricalcitol—Dyspepsia—Epirubicin—hematologic cancer	2.61e-05	6.48e-05	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—CREBBP—hematologic cancer	2.6e-05	0.00019	CbGpPWpGaD
Paricalcitol—Diarrhoea—Prednisone—hematologic cancer	2.59e-05	6.44e-05	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Methotrexate—hematologic cancer	2.59e-05	6.44e-05	CcSEcCtD
Paricalcitol—Nausea—Dexamethasone—hematologic cancer	2.58e-05	6.42e-05	CcSEcCtD
Paricalcitol—Nausea—Betamethasone—hematologic cancer	2.58e-05	6.42e-05	CcSEcCtD
Paricalcitol—Decreased appetite—Epirubicin—hematologic cancer	2.58e-05	6.4e-05	CcSEcCtD
Paricalcitol—Hypotension—Doxorubicin—hematologic cancer	2.56e-05	6.37e-05	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.56e-05	6.36e-05	CcSEcCtD
Paricalcitol—Fatigue—Epirubicin—hematologic cancer	2.56e-05	6.35e-05	CcSEcCtD
Paricalcitol—Pain—Epirubicin—hematologic cancer	2.53e-05	6.3e-05	CcSEcCtD
Paricalcitol—Constipation—Epirubicin—hematologic cancer	2.53e-05	6.3e-05	CcSEcCtD
Paricalcitol—Urticaria—Methotrexate—hematologic cancer	2.52e-05	6.25e-05	CcSEcCtD
Paricalcitol—Dizziness—Prednisone—hematologic cancer	2.51e-05	6.23e-05	CcSEcCtD
Paricalcitol—Body temperature increased—Methotrexate—hematologic cancer	2.5e-05	6.22e-05	CcSEcCtD
Paricalcitol—Abdominal pain—Methotrexate—hematologic cancer	2.5e-05	6.22e-05	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.5e-05	6.21e-05	CcSEcCtD
Paricalcitol—Insomnia—Doxorubicin—hematologic cancer	2.48e-05	6.16e-05	CcSEcCtD
Paricalcitol—Paraesthesia—Doxorubicin—hematologic cancer	2.46e-05	6.12e-05	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—PIK3CD—hematologic cancer	2.46e-05	0.00018	CbGpPWpGaD
Paricalcitol—Dyspnoea—Doxorubicin—hematologic cancer	2.44e-05	6.08e-05	CcSEcCtD
Paricalcitol—Feeling abnormal—Epirubicin—hematologic cancer	2.44e-05	6.07e-05	CcSEcCtD
Paricalcitol—Somnolence—Doxorubicin—hematologic cancer	2.44e-05	6.06e-05	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—ALB—hematologic cancer	2.43e-05	0.000177	CbGpPWpGaD
Paricalcitol—Gastrointestinal pain—Epirubicin—hematologic cancer	2.42e-05	6.02e-05	CcSEcCtD
Paricalcitol—Dyspepsia—Doxorubicin—hematologic cancer	2.41e-05	6e-05	CcSEcCtD
Paricalcitol—Vomiting—Prednisone—hematologic cancer	2.41e-05	5.99e-05	CcSEcCtD
Paricalcitol—Rash—Prednisone—hematologic cancer	2.39e-05	5.94e-05	CcSEcCtD
Paricalcitol—Dermatitis—Prednisone—hematologic cancer	2.39e-05	5.93e-05	CcSEcCtD
Paricalcitol—CYP3A4—Metabolism—PHYH—hematologic cancer	2.39e-05	0.000174	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GMPS—hematologic cancer	2.39e-05	0.000174	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—FTCD—hematologic cancer	2.39e-05	0.000174	CbGpPWpGaD
Paricalcitol—Decreased appetite—Doxorubicin—hematologic cancer	2.38e-05	5.92e-05	CcSEcCtD
Paricalcitol—Headache—Prednisone—hematologic cancer	2.37e-05	5.9e-05	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.37e-05	5.88e-05	CcSEcCtD
Paricalcitol—Fatigue—Doxorubicin—hematologic cancer	2.36e-05	5.87e-05	CcSEcCtD
Paricalcitol—Urticaria—Epirubicin—hematologic cancer	2.35e-05	5.85e-05	CcSEcCtD
Paricalcitol—Constipation—Doxorubicin—hematologic cancer	2.35e-05	5.83e-05	CcSEcCtD
Paricalcitol—Pain—Doxorubicin—hematologic cancer	2.35e-05	5.83e-05	CcSEcCtD
Paricalcitol—Abdominal pain—Epirubicin—hematologic cancer	2.34e-05	5.82e-05	CcSEcCtD
Paricalcitol—Body temperature increased—Epirubicin—hematologic cancer	2.34e-05	5.82e-05	CcSEcCtD
Paricalcitol—Hypersensitivity—Methotrexate—hematologic cancer	2.33e-05	5.8e-05	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—PIK3R1—hematologic cancer	2.32e-05	0.00017	CbGpPWpGaD
Paricalcitol—Asthenia—Methotrexate—hematologic cancer	2.27e-05	5.65e-05	CcSEcCtD
Paricalcitol—Feeling abnormal—Doxorubicin—hematologic cancer	2.26e-05	5.62e-05	CcSEcCtD
Paricalcitol—Nausea—Prednisone—hematologic cancer	2.25e-05	5.59e-05	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.24e-05	5.57e-05	CcSEcCtD
Paricalcitol—Pruritus—Methotrexate—hematologic cancer	2.24e-05	5.57e-05	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—PIK3CG—hematologic cancer	2.24e-05	0.000163	CbGpPWpGaD
Paricalcitol—Hypersensitivity—Epirubicin—hematologic cancer	2.18e-05	5.43e-05	CcSEcCtD
Paricalcitol—CYP3A4—Metabolism—SMPD3—hematologic cancer	2.18e-05	0.000159	CbGpPWpGaD
Paricalcitol—Urticaria—Doxorubicin—hematologic cancer	2.18e-05	5.41e-05	CcSEcCtD
Paricalcitol—Abdominal pain—Doxorubicin—hematologic cancer	2.17e-05	5.39e-05	CcSEcCtD
Paricalcitol—Body temperature increased—Doxorubicin—hematologic cancer	2.17e-05	5.39e-05	CcSEcCtD
Paricalcitol—Diarrhoea—Methotrexate—hematologic cancer	2.17e-05	5.38e-05	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—PIK3CB—hematologic cancer	2.15e-05	0.000157	CbGpPWpGaD
Paricalcitol—Asthenia—Epirubicin—hematologic cancer	2.13e-05	5.28e-05	CcSEcCtD
Paricalcitol—Pruritus—Epirubicin—hematologic cancer	2.1e-05	5.21e-05	CcSEcCtD
Paricalcitol—Dizziness—Methotrexate—hematologic cancer	2.09e-05	5.2e-05	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—CREBBP—hematologic cancer	2.08e-05	0.000152	CbGpPWpGaD
Paricalcitol—Diarrhoea—Epirubicin—hematologic cancer	2.03e-05	5.04e-05	CcSEcCtD
Paricalcitol—Hypersensitivity—Doxorubicin—hematologic cancer	2.02e-05	5.02e-05	CcSEcCtD
Paricalcitol—Vomiting—Methotrexate—hematologic cancer	2.01e-05	5e-05	CcSEcCtD
Paricalcitol—Rash—Methotrexate—hematologic cancer	2e-05	4.96e-05	CcSEcCtD
Paricalcitol—Dermatitis—Methotrexate—hematologic cancer	1.99e-05	4.96e-05	CcSEcCtD
Paricalcitol—Headache—Methotrexate—hematologic cancer	1.98e-05	4.93e-05	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—PIK3CD—hematologic cancer	1.97e-05	0.000144	CbGpPWpGaD
Paricalcitol—Asthenia—Doxorubicin—hematologic cancer	1.97e-05	4.89e-05	CcSEcCtD
Paricalcitol—Dizziness—Epirubicin—hematologic cancer	1.96e-05	4.87e-05	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—ALB—hematologic cancer	1.94e-05	0.000142	CbGpPWpGaD
Paricalcitol—Pruritus—Doxorubicin—hematologic cancer	1.94e-05	4.82e-05	CcSEcCtD
Paricalcitol—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.91e-05	0.000139	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ASNS—hematologic cancer	1.91e-05	0.000139	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—DCK—hematologic cancer	1.91e-05	0.000139	CbGpPWpGaD
Paricalcitol—Vomiting—Epirubicin—hematologic cancer	1.88e-05	4.68e-05	CcSEcCtD
Paricalcitol—Nausea—Methotrexate—hematologic cancer	1.88e-05	4.67e-05	CcSEcCtD
Paricalcitol—Diarrhoea—Doxorubicin—hematologic cancer	1.88e-05	4.66e-05	CcSEcCtD
Paricalcitol—Rash—Epirubicin—hematologic cancer	1.87e-05	4.64e-05	CcSEcCtD
Paricalcitol—Dermatitis—Epirubicin—hematologic cancer	1.87e-05	4.64e-05	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—PIK3R1—hematologic cancer	1.86e-05	0.000136	CbGpPWpGaD
Paricalcitol—Headache—Epirubicin—hematologic cancer	1.86e-05	4.61e-05	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—PTEN—hematologic cancer	1.85e-05	0.000135	CbGpPWpGaD
Paricalcitol—Dizziness—Doxorubicin—hematologic cancer	1.81e-05	4.51e-05	CcSEcCtD
Paricalcitol—CYP3A4—Metabolism—HDC—hematologic cancer	1.81e-05	0.000132	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—EP300—hematologic cancer	1.77e-05	0.000129	CbGpPWpGaD
Paricalcitol—Nausea—Epirubicin—hematologic cancer	1.76e-05	4.37e-05	CcSEcCtD
Paricalcitol—Vomiting—Doxorubicin—hematologic cancer	1.74e-05	4.33e-05	CcSEcCtD
Paricalcitol—Rash—Doxorubicin—hematologic cancer	1.73e-05	4.3e-05	CcSEcCtD
Paricalcitol—Dermatitis—Doxorubicin—hematologic cancer	1.73e-05	4.29e-05	CcSEcCtD
Paricalcitol—Headache—Doxorubicin—hematologic cancer	1.72e-05	4.27e-05	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—PIK3CB—hematologic cancer	1.72e-05	0.000125	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—MAPK3—hematologic cancer	1.71e-05	0.000125	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—MYC—hematologic cancer	1.66e-05	0.000121	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CDA—hematologic cancer	1.65e-05	0.000121	CbGpPWpGaD
Paricalcitol—Nausea—Doxorubicin—hematologic cancer	1.63e-05	4.05e-05	CcSEcCtD
Paricalcitol—CYP3A4—Metabolism—PC—hematologic cancer	1.59e-05	0.000116	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GBA—hematologic cancer	1.54e-05	0.000112	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SLC35B2—hematologic cancer	1.54e-05	0.000112	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PTEN—hematologic cancer	1.48e-05	0.000108	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—EP300—hematologic cancer	1.41e-05	0.000103	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—MTAP—hematologic cancer	1.41e-05	0.000103	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PIK3CA—hematologic cancer	1.31e-05	9.55e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—FHL2—hematologic cancer	1.25e-05	9.15e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—AGRN—hematologic cancer	1.23e-05	8.98e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—IDH2—hematologic cancer	1.17e-05	8.51e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HMMR—hematologic cancer	1.17e-05	8.51e-05	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—AKT1—hematologic cancer	1.15e-05	8.41e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ARNTL—hematologic cancer	1.1e-05	8e-05	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—AKT1—hematologic cancer	1.07e-05	7.8e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CA9—hematologic cancer	1.07e-05	7.78e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ACP5—hematologic cancer	1.07e-05	7.78e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NCOR2—hematologic cancer	1.05e-05	7.68e-05	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PIK3CA—hematologic cancer	1.05e-05	7.64e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—IDH1—hematologic cancer	1e-05	7.32e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ABCC3—hematologic cancer	9.91e-06	7.24e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTO1—hematologic cancer	9.91e-06	7.24e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—TXN—hematologic cancer	9.91e-06	7.24e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SPHK1—hematologic cancer	9.7e-06	7.08e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—UGT1A1—hematologic cancer	9.32e-06	6.8e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CRABP1—hematologic cancer	9.06e-06	6.62e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SLC22A1—hematologic cancer	9.06e-06	6.62e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALOX5—hematologic cancer	8.83e-06	6.45e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NUP98—hematologic cancer	8.56e-06	6.25e-05	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—AKT1—hematologic cancer	8.54e-06	6.24e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ADCY7—hematologic cancer	8.31e-06	6.06e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NCOA3—hematologic cancer	8.31e-06	6.06e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NUP214—hematologic cancer	8.25e-06	6.02e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—MTR—hematologic cancer	8.08e-06	5.9e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ABCG2—hematologic cancer	8.08e-06	5.9e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ENO2—hematologic cancer	7.92e-06	5.78e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTT1—hematologic cancer	7.68e-06	5.61e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SDC1—hematologic cancer	7.51e-06	5.48e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CD44—hematologic cancer	6.39e-06	4.66e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NQO1—hematologic cancer	6.39e-06	4.66e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYCS—hematologic cancer	6.04e-06	4.41e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	6e-06	4.38e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTP1—hematologic cancer	5.33e-06	3.89e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ABCB1—hematologic cancer	5.04e-06	3.68e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTM1—hematologic cancer	4.89e-06	3.57e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NCOR1—hematologic cancer	4.89e-06	3.57e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—MTHFR—hematologic cancer	4.33e-06	3.16e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PIK3CG—hematologic cancer	3.63e-06	2.65e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CREBBP—hematologic cancer	3.37e-06	2.46e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PIK3CD—hematologic cancer	3.2e-06	2.33e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALB—hematologic cancer	3.15e-06	2.3e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PIK3R1—hematologic cancer	3.02e-06	2.2e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.79e-06	2.03e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PTEN—hematologic cancer	2.41e-06	1.76e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—EP300—hematologic cancer	2.3e-06	1.68e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.7e-06	1.24e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—AKT1—hematologic cancer	1.39e-06	1.01e-05	CbGpPWpGaD
